Evidence map›Paper›PMID 26483482›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Preventing fibril formation of a protein by selective mutation.

Gia G Maisuradze, Jordi Medina, Khatuna Kachlishvili, Pawel Krupa, Magdalena A Mozolewska, Pau Martin-Malpartida, Luka Maisuradze, Maria J Macias, Harold A Scheraga

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Computational Models for the Study of Protein Aggregation.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Gia G MaisuradzeBaker Laboratory of Chemistry and Chemical Biology, Cornell University, Ithaca, NY 14853-1301; gm56@cornell.edu maria.macias@irbbarcelona.org has5@cornell.edu.
Jordi MedinaStructural Characterization of Macromolecular Assemblies, Institute for Research in Biomedicine, The Barcelona Institute of Science and Technology, Barcelona, 08028, Spain;
Khatuna KachlishviliBaker Laboratory of Chemistry and Chemical Biology, Cornell University, Ithaca, NY 14853-1301;
Pawel KrupaBaker Laboratory of Chemistry and Chemical Biology, Cornell University, Ithaca, NY 14853-1301; Laboratory of Molecular Modeling, Faculty of Chemistry, University of Gdańsk, 80-308 Gdańsk, Poland;
Magdalena A MozolewskaBaker Laboratory of Chemistry and Chemical Biology, Cornell University, Ithaca, NY 14853-1301; Laboratory of Molecular Modeling, Faculty of Chemistry, University of Gdańsk, 80-308 Gdańsk, Poland;
Pau Martin-MalpartidaStructural Characterization of Macromolecular Assemblies, Institute for Research in Biomedicine, The Barcelona Institute of Science and Technology, Barcelona, 08028, Spain;
Luka MaisuradzeBaker Laboratory of Chemistry and Chemical Biology, Cornell University, Ithaca, NY 14853-1301;
Maria J MaciasStructural Characterization of Macromolecular Assemblies, Institute for Research in Biomedicine, The Barcelona Institute of Science and Technology, Barcelona, 08028, Spain; Catalan Institution for Research and Advanced Studies, Barcelona, 08010, Spain gm56@cornell.edu maria.macias@irbbarcelona.org has5@cornell.edu.
Harold A ScheragaBaker Laboratory of Chemistry and Chemical Biology, Cornell University, Ithaca, NY 14853-1301; gm56@cornell.edu maria.macias@irbbarcelona.org has5@cornell.edu.
Cornell University · USInstitute for Research in Biomedicine · ESUniversity of Gdańsk · PL

Funding

INTERNAL BONDIN IN PROTEINSR01GM014312 · NIGMS · CORNELL UNIVERSITY ITHACA · PI MAISURADZE, GIA, RACKOVSKY, SHALOM R · 1985 to 2021
$9.4M
NIGMS NIH HHS GM-14312NIGMS NIH HHS R01 GM014312
6 · The paper itself

Abstract

The origins of formation of an intermediate state involved in amyloid formation and ways to prevent it are illustrated with the example of the Formin binding protein 28 (FBP28) WW domain, which folds with biphasic kinetics. Molecular dynamics of protein folding trajectories are used to examine local and global motions and the time dependence of formation of contacts between C(α)s and C(β)s of selected pairs of residues. Focus is placed on the WT FBP28 WW domain and its six mutants (L26D, L26E, L26W, E27Y, T29D, and T29Y), which have structures that are determined by high-resolution NMR spectroscopy. The origins of formation of an intermediate state are elucidated, viz. as formation of hairpin 1 by a hydrophobic collapse mechanism causing significant delay of formation of both hairpins, especially hairpin 2, which facilitates the emergence of an intermediate state. It seems that three-state folding is a major folding scenario for all six mutants and WT. Additionally, two-state and downhill folding scenarios were identified in ∼ 15% of the folding trajectories for L26D and L26W, in which both hairpins are formed by the Matheson-Scheraga mechanism much faster than in three-state folding. These results indicate that formation of hairpins connecting two antiparallel β-strands determines overall folding. The correlations between the local and global motions identified for all folding trajectories lead to the identification of the residues making the main contributions in the formation of the intermediate state. The presented findings may provide an understanding of protein folding intermediates in general and lead to a procedure for their prevention.

Indexed as

MutationAlgorithmsAmyloidCarrier ProteinsCrystallography, X-RayHumansKineticsMolecular Dynamics SimulationProtein FoldingProteinsProtein Structure, SecondaryProtein Structure, TertiaryThermodynamicsAmyloidCarrier Proteinsformin binding protein 28, humanProteinsFBP28 WW domainfibril formationhigh-resolution NMR spectroscopymillisecond-timescale MD simulationsselective mutation

Identifiers

PMID26483482
PMCPMC4640778
OpenAlexW2140429615

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.